HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,227,052 | +0.7% | 14,832 | +3.8% | 0.21% | +4.5% |
Q1 2024 | $1,219,055 | +26.3% | 14,283 | +26.5% | 0.20% | +8.2% |
Q4 2023 | $965,323 | -3.7% | 11,289 | +0.9% | 0.18% | -10.3% |
Q3 2023 | $1,002,222 | +8.0% | 11,188 | +2.6% | 0.20% | +9.1% |
Q2 2023 | $928,197 | +4.1% | 10,902 | +1.1% | 0.19% | +1.1% |
Q1 2023 | $891,963 | +5.2% | 10,779 | -0.0% | 0.18% | +2.8% |
Q4 2022 | $847,847 | +8.7% | 10,780 | +2.3% | 0.18% | -2.7% |
Q3 2022 | $780,000 | +17.3% | 10,542 | +3.3% | 0.18% | +21.7% |
Q2 2022 | $665,000 | +9.2% | 10,205 | +5.9% | 0.15% | +23.6% |
Q1 2022 | $609,000 | +41.3% | 9,637 | +18.7% | 0.12% | +44.7% |
Q4 2021 | $431,000 | -22.1% | 8,121 | +3.7% | 0.08% | -29.2% |
Q3 2021 | $553,000 | +17.4% | 7,828 | +10.8% | 0.12% | +21.2% |
Q2 2021 | $471,000 | -48.0% | 7,067 | -13.4% | 0.10% | -50.5% |
Q1 2021 | $905,000 | -5.5% | 8,156 | +1.1% | 0.20% | -11.9% |
Q4 2020 | $958,000 | +39.4% | 8,068 | +2.5% | 0.23% | +20.1% |
Q3 2020 | $687,000 | +1.5% | 7,872 | +4.1% | 0.19% | -3.1% |
Q2 2020 | $677,000 | -4.6% | 7,561 | +6.0% | 0.20% | -17.0% |
Q1 2020 | $710,000 | -22.1% | 7,130 | -10.1% | 0.24% | -0.8% |
Q4 2019 | $911,000 | -10.1% | 7,927 | -1.4% | 0.24% | -15.4% |
Q3 2019 | $1,013,000 | +3.9% | 8,036 | -0.8% | 0.28% | +1.1% |
Q2 2019 | $975,000 | +35.0% | 8,102 | -1.9% | 0.28% | +34.5% |
Q1 2019 | $722,000 | -10.9% | 8,260 | +2.0% | 0.21% | -22.8% |
Q4 2018 | $810,000 | -10.9% | 8,100 | +2.1% | 0.27% | +3.9% |
Q3 2018 | $909,000 | +28.4% | 7,937 | +0.5% | 0.26% | +20.1% |
Q2 2018 | $708,000 | +24.0% | 7,898 | +1.2% | 0.21% | +19.6% |
Q1 2018 | $571,000 | -33.9% | 7,807 | -47.5% | 0.18% | -31.4% |
Q4 2017 | $864,000 | +28.2% | 14,879 | -1.0% | 0.26% | +22.5% |
Q3 2017 | $674,000 | +24.8% | 15,029 | +10.0% | 0.21% | +19.0% |
Q2 2017 | $540,000 | +13.0% | 13,666 | +16.1% | 0.18% | +3.5% |
Q1 2017 | $478,000 | +2.6% | 11,773 | +1.7% | 0.17% | -2.3% |
Q4 2016 | $466,000 | +29.8% | 11,580 | +16.8% | 0.18% | +25.5% |
Q3 2016 | $359,000 | +39.1% | 9,916 | +11.3% | 0.14% | +34.3% |
Q2 2016 | $258,000 | -10.4% | 8,906 | +8.0% | 0.10% | -13.2% |
Q1 2016 | $288,000 | +21.5% | 8,247 | +12.4% | 0.12% | +9.0% |
Q3 2015 | $237,000 | -9.9% | 7,337 | +15.3% | 0.11% | -3.5% |
Q2 2015 | $263,000 | +13.9% | 6,366 | +23.7% | 0.12% | +17.3% |
Q1 2015 | $231,000 | – | 5,147 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |